Years of lamenting the inefficiencies of paper-driven clinical trials have led to a stunning revolution — the sector is now awash in technology, but it is not at all clear that this is a positive development. Investigative sites are being inundated with technologies, most of which do not communicate with each other, leaving end users to log into and out of numerous portals to enter or review information to conduct clinical trials. And despite the crush of new technologies, there is little evidence that they are helping sponsors and contract research organizations (CROs) collaborate with sites, or enabling them to become more competitive through improved clinical trial performance.
Sites are always on the outlook for future studies. It is their lifeblood, so they are quite aware that their chances of securing new studies are better if they know how they are performing against expectations. So, in a world of technology overload, purpose-built technology with workflows that make a site's job easier and facilitate the sharing of this information among stakeholders is a game changer.
Cloud-based tools that facilitate the flow of information among stakeholders help to create the transparent atmosphere that sites are looking for. With the aid of workflows that identify the tasks awaiting completion, the workload at the site is simplified, sites become more engaged, and sponsors and CROs can more easily share performance results with sites, building a foundation for a mutually beneficial collaboration.
Download this white paper "More Collaboration with Investigative Sites: Less Technology Overload Delivers Transparency and Efficiencies" to learn about how sites struggling under the weight of too much technology, yet looking for a more robust collaboration and transparency process can benefit from automated workflows in the initiation of clinical trials.